News related to Glucagen (Glucagon) and/or conditions it is approved for
Researchers Face Off Over Incretin Risk Source: MedPageToday.com - medical news plus CME for physicians [2013.05.17] (MedPage Today) -- As concerns escalate over the potential risks of glucagon-like peptide-1 (GLP-1)-based therapies, a diabetes journal hosted a point-counterpoint debate between the researchers who have been the leading voices on each side of the issue.